Singleplex Immunoassay Market Overview

Global singleplex immunoassay market to find lucrative growth opportunities in the forthcoming years. Market Research Future (MRFR) reports that the market will expand at a CAGR of 8.4%. Singleplex immunoassays have become common medical products in recent years. Western blotting or Enzyme-Linked Immunosorbent Assays (ELISA) has become a popular singleplex immunoassays as they are increasingly utilized to analysing extracellular proteins and multiple intracellular. Their use has also increased owing to advantages such as fast and high-through output in procedures such as gene expression quantification.

Immunoassays are highly adaptable which are designed to detect the binding of the specific antibody to the target analyte. Singleplex immunoassays are generally used to analyze multiple intracellular and extracellular proteins and gene expression quantification.The global Singleplex Immunoassay Market is driven by various factors such as growth in pharmaceutical and biotechnology sector, growing prevalence of chronic diseases, and raising awareness about immunoassay. Moreover, increased focus on diagnostic testing and growing government assistance are fueling the growth of the global singleplex immunoassay market. Additionally, many prominent players are engaged in the development of singleplex immunoassays products to maintain their market position. For instance, BioVendor develops and markets Q-Plex Human iL-7 kit for singleplex immunoassays.

Increased focus on application-specific signleplex immunoassay is also expected to favour the market during the forecast period. For example, Thermo Fisher Scientific’s developed a unique singleplex assay “QuantiGene Singleplex assay” to identify DNA or RNA volume using signal amplification. The global singleplex immunoassay market is also gathering momentum due to the rapid expansion of the biotechnology and pharmaceutical sector. Moreover, growing popularity of immunoassay in oncology and fast adoption of rental immunoassay analyzers are other important factors creating market opportunities. It is anticipated that prevalence of chronic disorders will rise further in the near future, which will influence singleplex immunoassay demand.

Singleplex Immunoassay Market Segmentation

MRFR’s report includes a thorough segmental analysis of the global singleplex immunoassay market based on technology, product and service, end-user, application and type.

By technology, the market has been segmented into fluorescence detection, flow cytometry and others. By product and services, the market has been segmented into instruments, consumables and others. By end-user, the market has been segmented into reference laboratories, hospitals research institutes, pharmaceutical biotechnology companies and others. By application, the market has been segmented into clinical diagnostics, research and development (RD) and others. The RD segment covers biomarker discovery and validation and drug discovery development. The clinical diagnostics segment covers cancer, autoimmune diseases, metabolism endocrinology disorders, infectious diseases, nervous system disorders and cardiovascular diseases. By type, the market has been segmented into cell-based assays, nucleic acid-based assays, protein-based assays and others.

Singleplex Immunoassay Market Regional Segmentation

Key regions discussed in the report include Europe, Americas, the Middle East Africa (MEA), and Asia Pacific. In terms of revenue, Americas make a significant contribution to the global singleplex immunoassay market. The region is home to various globally leading market participants has a positive impact on the Americas market. In addition, growing incidences of infectious diseases and high healthcare spending in countries such as the U.S. and Canada are among the key factors supporting the market growth during the forecast period.

Europe is also viewed as a key market for singleplex immunoassay. Factors such rising prevalence of chronic disorders within the region, advances in immunoassay, and strong RD pipeline provide an impetus to the region’s market.

Though APAC is behind Americas and Europe when it comes to market share, the market in the region is expected to witness the fastest growth during the forecast period. Expanding patient pool, improving healthcare service standards and increased investment in RD programs are some of factors expected to drive the growth of APAC singleplex immunoassay market during the forecast period.

Singleplex Immunoassay Market Players

• Luminex
• Thermo Fisher Scientific
• Illumina
• Bio-Rad Laboratories
• QIAGEN N.V
• Abcam
• Becton Dickinson and Company
• Merck Life sciences
• Agilent Technologies
• Quanterix
• Bio-Techne
• Olink
• Seegene
• BioVendor
• Others

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/singleplex-immunoassay-market-6196

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com